Stocks
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -356.1 | 308.7 | -628.3 | -515.4 | -474.6 | -240.4 | ||
| Changes by years, y/y, % | +51% | -187% | -304% | -18% | -8% | +14.9% | |||
Blueprint Medicines Corporation. EBITDA US GAAP, bln rub
Blueprint Medicines Corporation. EBITDA US GAAP, changes, %
Blueprint Medicines Corporation. EBITDA US GAAP, sum by quarters, bln rub
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -115.2 | -103.6 | -74.0 | -29.5 | -33.4 | -240.4 | |
| Changes by years, y/y, % | -6% | -31% | -40% | -77% | -71% | |||
| Changes by quarters, q/q, % | -10% | -10% | -29% | -60% | +13% | |||
